S.No. |
Title |
Source Title |
Authors |
DOI |
Citing Works Count |
1 |
Neuroprotective and Preventative Effects of Molecular Hydrogen
|
Current Pharmaceutical Design
|
Mami Noda; Jiankang Liu; Jiangang Long
|
10.2174/1381612826666201019103020
|
0
|
2 |
TRPC3-Based Protein Signaling Complex as a Therapeutic Target of Myocardial Atrophy.
|
Current Molecular Pharmacology
|
Kazuhiro Nishiyama; Tomohiro Tanaka; Akiyuki Nishimura; Motohiro Nishida
|
10.2174/1874467213666200407090121
|
1
|
3 |
Microglial Cathepsin B and Porphyromonas gingivalis Gingipains as Potential Therapeutic Targets for Sporadic Alzheimer's Disease.
|
CNS & Neurological Disorders Drug Targets
|
Hiroshi Nakanishi; Saori Nonaka; Zhou Wu
|
10.2174/1871527319666200708125130
|
1
|
4 |
Glia-driven neuroinflammation and systemic inflammation in Alzheimer's disease.
|
Current Neuropharmacology
|
Sadayuki Hashioka; Zhou Wu; Andis Klegeris
|
10.2174/1570159x18666201111104509
|
0
|
5 |
Identification of 2-Fluoropalmitic Acid as a Potential Therapeutic Agent Against Glioblastoma.
|
Current Pharmaceutical Design
|
Shabierjiang Jiapaer; Takuya Furuta; Yu Dong; Tomohiro Kitabayashi; Hemragul Sabit; Jiakang Zhang; Guangtao Zhang; Shingo Tanaka; Masahiko Kobayashi; Atsushi Hirao; Mitsutoshi Nakada
|
10.2174/1381612826666200429092742
|
1
|
6 |
Helicobacter suis Infection in Mouse Induced not Only Gastric, but Hepatic and Pulmonary MALT Lymphoma: Relation to Substance P
|
Current Pharmaceutical Design
|
Masahiko Nakamura; Yosuke Kodama; Anders Øverby; Shin'ichi Takahashi; Koichi Ohshima; Hidekazu Suzuki; Somay Yamagata Murayama; Hidenori Matsui
|
10.2174/1381612826666200424163506
|
2
|
7 |
Recent Advances in the Understanding of the Reaction Chemistries of the Heme Catabolizing Enzymes HO and BVR Based on High Resolution Protein Structures.
|
Current Medicinal Chemistry
|
Masakazu Sugishima; Kei Wada; Keiichi Fukuyama
|
10.2174/0929867326666181217142715
|
4
|
8 |
Effects of Dietary Intake and Supplementation of Fatty Acids on Cardiometabolic Disorders in Humans: a Lesson from a Large Number of Meta-Analyses
|
Letters In Drug Design & Discovery
|
Sho-ichi Yamagishi and Takanori Matsui
|
10.2174/1570180816666181107113148
|
0
|
9 |
Pathological Role of Advanced Glycation End Products (AGEs) and their Receptor Axis in Atrial Fibrillation.
|
Mini Reviews In Medicinal Chemistry
|
Sho-ichi Yamagishi; Ami Sotokawauchi; Takanori Matsui
|
10.2174/1389557519666190311140737
|
5
|
10 |
Switching Dipeptidyl Peptidase-4 Inhibitors to Tofogliflozin, a Selective Inhibitor of Sodium-Glucose Cotransporter 2 Improve Arterial Stiffness Evaluated by Cardio-Ankle Vascular Index in Patients with Type 2 Diabetes: A Pilot Study
|
Current Vascular Pharmacology
|
Munehisa Bekki; Nobuhiro Tahara; Atsuko Tahara; Sachiyo Igata; Akihiro Honda; Yoichi Sugiyama; Tomohisa Nakamura; Jiahui Sun; Yuki Kumashiro; Takanori Matsui; Yoshihiro Fukumoto; Sho-ichi Yamagishi
|
10.2174/1570161116666180515154555
|
16
|
11 |
Therapeutic Potential of Pigment Epithelium-derived Factor in Cancer.
|
Current Pharmaceutical Design
|
Sho-ichi Yamagishi; Yoshinori Koga; Ami Sotokawauchi; Naoki Hashizume; Suguru Fukahori; Takanori Matsui; Minoru Yagi
|
10.2174/1381612825666190319112106
|
2
|
12 |
Biomechanics of the Healthy and Keratoconic Corneas: A Combination of the Clinical Data, Finite Element Analysis, and Artificial Neural Network.
|
Current Pharmaceutical Design
|
Alireza Karimi; Najme Meimani; Reza Razaghi; Seyed Mohammadali Rahmati; Khosrow Jadidi; Mostafa Rostami
|
10.2174/1381612825666181224123939
|
5
|
13 |
Patient-specific finite element model of coronary artery stenting
|
Current Pharmaceutical Design
|
Reza Razaghi; Alireza Karimi; Ramezan Ali Taheri
|
10.2174/1381612825666181204115124
|
4
|
14 |
A Recombinant Fab Antibody Against Kwakhurin as a Tool for Sensitive Indirect Competitive ELISA.
|
Current Pharmaceutical Biotechnology
|
Kaskamol Chanpokapaiboon; Pichayatri Khoonrit; Gorawit Yusakul; Thaweesak Juengwatanatrakul; Waraporn Putalun; Hiroyuki Tanaka; Seiichi Sakamoto; Satoshi Morimoto
|
10.2174/1389201020666181226105223
|
3
|
15 |
The Value of Urinary Cystatin C Level to Predict Neonatal Kidney Injury.
|
Current Pharmaceutical Design
|
Nastaran Khosravi; Masoud Zadkarami; Farhad Abolhasan Chobdar; Rozita Hoseini; Nasrin Khalesi; Parsa Panahi; Alireza Karimi
|
10.2174/1381612824666180918100819
|
3
|
16 |
Therapeutic potential of DNA-aptamers raised against AGE-RAGE axis in diabetes-related complications
|
Current Pharmaceutical Design
|
Sho-ichi Yamagishi; Takanori Matsui
|
10.2174/1381612824666180829110124
|
12
|
17 |
The Efficacy of Omega-3 Supplement on Prevention of Retinopathy of Prematurity in Premature Infants: A Randomized Double-blinded Controlled trial.
|
Current Pharmaceutical Design
|
Nasrin Khalesi; Arash Bordbar; Nastaran Khosravi; Morteza Kabirian; Alireza Karimi
|
10.2174/1381612824666180601094849
|
4
|
18 |
The Influence of Pre-Analytical Factors on the Analysis of Circulating MicroRNA.
|
MicroRNA (Shariqah, United Arab Emirates)
|
Hiromichi Shiotsu; Kazuhiro Okada; Tatsuki Shibuta; Yuki Kobayashi; Saki Shirahama; Chieri Kuroki; Saori Ueda; Masanori Ohkuma; Katsuyoshi Ikeda; Yukio Ando; Hirotaka Matsui; Yuzo Kayamori; Tsukuru Umemura
|
10.2174/2211536607666180709143335
|
4
|
19 |
Pigment Epithelium-Derived Factor: A Novel Therapeutic Target for Cardiometabolic Diseases and Related Complications.
|
Current Medicinal Chemistry
|
Sho-ichi Yamagishi; Takanori Matsui
|
10.2174/0929867324666170608103140
|
9
|
20 |
Synergic Strategies for the Enhanced Self-Assembly of Biomineralization Peptides for the Synthesis of Functional Nanomaterials.
|
Protein And Peptide Letters
|
Jose Isagani B. Janairo; Tatsuya Sakaguchi; Kenta Mine; Rui Kamada; Kazuyasu Sakaguchi
|
10.2174/0929866525666171214110206
|
5
|
21 |
Angiotensin I Converting Enzyme-inhibiting Peptides Purified from Elastase-degraded Elastin Prepared from Pig Aorta
|
Current Enzyme Inhibition
|
Iori Maeda; Shohei Kai; Suguru Taniguchi; Asako Inoue; Hujun Li; Hitoshi Kesamaru; Takeru Nose
|
10.2174/1573408013666170912113121
|
0
|
22 |
Oncolytic Herpes Simplex Virus Vectors Fully Retargeted to Tumor- Associated Antigens.
|
Current Cancer Drug Targets
|
Hiroaki Uchida; Hirofumi Hamada; Kenji Nakano; Heechung Kwon; Hideaki Tahara; Justus B. Cohen; Joseph C Glorioso
|
10.2174/1568009617666170206105855
|
12
|
23 |
Chemical Crosslinking: Role in Protein and Peptide Science.
|
Current Protein & Peptide Science
|
Bharti Arora; Rashmi Tandon; Pankaj Attri; Rohit Bhatia
|
10.2174/1389203717666160724202806
|
14
|
24 |
L-Carnitine Supplementation Improves Self-Rating Depression Scale Scores in Uremic Male Patients Undergoing Hemodialysis.
|
Letters In Drug Design & Discovery
|
Kyoko Tashiro; Yusuke Kaida; Sho-ichi Yamagishi; Hideharu Tanaka; Miyuki Yokoro; Junko Yano; Kazuko Sakai; Yuka Kurokawa; Kensei Taguchi; Yosuke Nakayama; Takahiro Inokuchi; Kei Fukami
|
10.2174/1570180814666170216102632
|
4
|
25 |
Phytochemicals Against Advanced Glycation End Products (AGEs) and the Receptor System.
|
Current Pharmaceutical Design
|
Sho-ichi Yamagishi; Takanori Matsui; Yuji Ishibashi; Fumiyuki Isami; Yumi Abe; Tatsuya Sakaguchi; Yuichiro Higashimoto
|
10.2174/1381612822666161021155502
|
11
|
26 |
Anagliptin, A Dipeptidyl Peptidase-4 Inhibitor Ameliorates Arterial Stiffness in Association with Reduction of Remnant-Like Particle Cholesterol and Alanine Transaminase Levels in Type 2 Diabetic Patients
|
Current Vascular Pharmacology
|
Nobuhiro Tahara; Sho-ichi Yamagishi; Munehisa Bekki; Norihiro Kodama; Tomohisa Nakamura; Yoichi Sugiyama; Tamami Oshige; Yuki Kumashiro; Akihiro Honda; Atsuko Tahara; Sachiyo Igata; Yoshihiro Fukumoto
|
10.2174/1570161114666160625090212
|
13
|
27 |
Cationic Lipid Content in Liposome-Encapsulated Nisin Improves Sustainable Bactericidal Activity against Streptococcus mutans
|
The Open Dentistry Journal
|
Kazuo Yamakami; Hideaki Tsumori; Yoshitaka Shimizu; Yutaka Sakurai; Kohei Nagatoshi; Kenji Sonomoto
|
10.2174/1874210616021001360
|
4
|
28 |
Late Anterior Dislocation Due to Posterior Pelvic Tilt in Total Hip Arthroplasty
|
The Open Orthopaedics Journal
|
Hiroki Kobayashi; Yasuharu Nakashima; Takuaki Yamamoto; Goro Motomura; Masayuki Kanazawa; Kenji Takagishi; Yukihide Iwamoto
|
10.2174/1874325001610010206
|
13
|
29 |
The Epidemiology of Sleep Disordered Breathing and Hypertension in Various Populations.
|
Current Hypertension Reviews
|
Hiroyuki Sawatari; Akiko Chishaki; Shin Ich Ando
|
10.2174/1573402112666160114093307
|
10
|
30 |
Behind the Snoring.
|
Current Hypertension Reviews
|
Shin-ichi Ando
|
10.2174/157340211201160304174142
|
0
|
31 |
Dysfunction of Glutamate Receptors in Microglia May Cause Neurodegeneration.
|
Current Alzheimer Research
|
Mami Noda
|
10.2174/1567205013666151116125810
|
20
|
32 |
The Effect of Lightly Gripping a Cane on the Dynamic Balance Control
|
The Open Biomedical Engineering Journal
|
Kazushige Oshita; Sumio Yano
|
10.2174/1874120701509010146
|
9
|
33 |
Structure, Function, and Signaling of Taste G-Protein-Coupled Receptors
|
Current Pharmaceutical Biotechnology
|
Keisuke Sanematsu; Ryusuke Yoshida; Noriatsu Shigemura; Yuzo Ninomiya
|
10.2174/1389201015666140922105911
|
17
|
34 |
Therapeutic angiogenesis: recent and future prospects of gene therapy in peripheral artery disease.
|
Current Gene Therapy
|
Michiko Tanaka; Kikuko Taketomi; Yoshikazu Yonemitsu
|
10.2174/156652321404140902124838
|
6
|
35 |
Spinal cord is the primary site of action of the cannabinoid CB2 receptor agonist JWH133 that suppresses neuropathic pain: Possible involvement of microglia
|
The Open Pain Journal
|
Hiroshi Shimoyama; Makoto Tsuda; Takahiro Masuda; Ryohei Yoshinaga; Keiko Tsukamoto; Hidetoshi Tozaki-Saitoh; Kazuhide Inoue
|
10.2174/1876386301407010001
|
1
|
36 |
Gene-Based Therapeutic Angiogenesis for Peripheral Arterial Disease.
|
Current Gene Therapy
|
Michiko Tanaka; Kikuko Taketomi; Yoshikazu Yonemitsu
|
|
0
|
37 |
Role of AGEs-RAGE System in Cardiovascular Disease
|
Current Pharmaceutical Design
|
Kei Fukami; Sho-ichi Yamagishi; Seiya Okuda
|
10.2174/13816128113199990475
|
112
|
38 |
Taste Transductions in Taste Receptor Cells: Basic Tastes and Moreover
|
Current Pharmaceutical Design
|
Shusuke Iwata; Ryusuke Yoshida; Yuzo Ninomiya
|
10.2174/13816128113199990575
|
40
|
39 |
Microarray Technologies for Intracellular Kinome Analysis
|
Current Medicinal Chemistry
|
Tatsuhiro Yamamoto; Takeshi Mori; Yoshiki Katayama
|
10.2174/0929867321666131212154153
|
5
|
40 |
Pigment epithelium-derived factor (PEDF) and cardiometabolic disorders.
|
Current Pharmaceutical Design
|
Sho-ichi Yamagishi; Takanori Matsui
|
10.2174/13816128113199990473
|
27
|
41 |
Molecular imaging of vascular inflammation.
|
Current Pharmaceutical Design
|
Nobuhiro Tahara; Atsuko Tahara; Akihiro Honda; Yoshikazu Nitta; Norihiro Kodama; Sho-ichi Yamagishi; Tsutomu Imaizumi
|
10.2174/13816128113199990479
|
11
|
42 |
Role of Asymmetric Dimethylarginine in Cardiorenal Syndrome
|
Current Pharmaceutical Design
|
Seiji Ueda; Sho-ichi Yamagishi; Miyuki Yokoro; Seiya Okuda
|
10.2174/13816128113199990480
|
20
|
43 |
Personalized peptide vaccine for treatment of advanced cancer.
|
Current Medicinal Chemistry
|
Tetsuro Sasada; Akira Yamada; Masanori Noguchi; Kyogo Itoh
|
10.2174/0929867321666140205132936
|
40
|
44 |
Cationic comb-type copolymer excludes intercalating dye from DNA without inducing DNA condensation
|
Current Nanoscience
|
Atsushi Maruyama; Naotaka Sonda; Kohei Yamasaki; Masanori Hirano; Satoru Kidoaki; Naohiko Shimada; Masatoshi Maeshiro; Masaya Miyazaki
|
10.2174/1573413709666131129000024
|
3
|
45 |
A peptide microarray fabricated on a non-fouling phosphatidylcholine-polymer-coated surface for a high-fidelity analysis of a cellular kinome
|
Current Medicinal Chemistry
|
Hiromu Ikeda; Jumpei Kamimoto; Tatsuhiro Yamamoto; Akito Hata; Y. Otsubo; Takuro Niidome; Masamichi Fukushima; Takeshi Mori; Yoshiki Katayama
|
10.2174/09298673113209990142
|
4
|
46 |
Biotransformation of Khellin to Khellol by Aspergillus Niger and the Evaluation of their Biological Activities
|
The Open Bioactive Compounds Journal
|
Ahmed Ashour; Saleh H. El-Sharkawy; Mohamed Amer; Fatma M. Abdel Bar; Amira Mera; Toshiro Nagata; Ryuichiro Kondo; Kuniyoshi Shimizu
|
10.2174/1874847320130628001
|
2
|
47 |
Editorial: Novel Therapeutic Targets for Cardiovascular Disease.
|
Current Pharmaceutical Design
|
Sho-ichi Yamagishi
|
10.2174/13816128113199990481
|
0
|
48 |
Preparation of Novel Isotropic Pitch with High Softening Point and Solvent Solubility for Pitch-based Electrospun Carbon Nanofiber
|
Current Organic Chemistry
|
Byung Jun Kim; Hyun-Sig Kil; Naoki Watanabe; Min Hyun Seo; Bo Hye Kim; Kap Seung Yang; Osamu Kato; Jin Miyawaki; Isao Mochida; Seong Ho Yoon
|
10.2174/1385272811317130013
|
26
|
49 |
Castration-resistant Prostate Cancer: Novel Therapeutics Pre- or Post- Taxane Administration
|
Current Cancer Drug Targets
|
Masaki Shiota; Akira Yokomizo; Naohiro Fujimoto; Hidetoshi Kuruma; Seiji Naito
|
10.2174/15680096113139990078
|
16
|
50 |
Redox control of cardiovascular homeostasis by angiotensin II
|
Current Pharmaceutical Design
|
Caroline Sunggip; Naoyuki Kitajima; Motohiro Nishida
|
10.2174/1381612811319170008
|
10
|
51 |
Regulation of angiotensin II receptor expression.
|
Current Pharmaceutical Design
|
Toshihiro Ichiki
|
10.2174/1381612811319170007
|
9
|
52 |
Fatty acid intakes and coronary heart disease mortality in Japan: NIPPON DATA90, 1990-2005
|
Current Nutrition & Food Science
|
Yasuyuki Nakamura; Yutaka Kiyohara; Nagako Okuda; Tomonori Okamura; Aya Higashiyama; Makoto Watanabe; Aya Kadota; Shin-ya Nagasawa; Naoko Miyagawa; Takayoshi Ohkubo; Yoshikuni Kita; Katsuyuki Miura; Akira Okayama; Hirotsugu Ueshima
|
10.2174/1573401311309010006
|
3
|
53 |
Intracellular accumulation of toxic turn amyloid-β is associated with endoplasmic reticulum stress in Alzheimer's disease.
|
Current Alzheimer Research
|
Naoko Soejima; Yasumasa Ohyagi; Norimichi Nakamura; Eri Himeno; Kyoko Iinuma; Nobutaka Sakae; Ryo Yamasaki; Takeshi Tabira; Kazuma Murakami; Kazuhiro Irie; Noriaki Kinoshita; Frank M. LaFerla; Yutaka Kiyohara; Toru Iwaki; Jun Ichi Kira
|
10.2174/156720513804871372; 10.2174/1567205011310010003
|
47
|
54 |
L-DOPA suppressed scratching behavior and modified brain monoamine/amino acid concentrations in mice
|
Letters In Drug Design & Discovery
|
Yoriko Akimoto; Shinobu Yasuo; Mitsuhiro Furuse
|
10.2174/1570180811310030002
|
0
|
55 |
Neurotransmitters, psychotropic drugs and microglia: clinical implications for psychiatry.
|
Current Medicinal Chemistry
|
Takahiro A. Kato; Yusuke Yamauchi; Hideki Horikawa; Akira Monji; Yoshito Mizoguchi; Y. Seki; Kohei Hayakawa; Hideo Utsumi; Shigenobu Kanba
|
10.2174/0929867311320030003
|
53
|
56 |
IL-4 and IL-12 Polymorphisms are Associated with Response to Suplatast Tosilate, a Th2 Cytokine Inhibitor, in Patients with Atopic Dermatitis
|
The Open Dermatology Journal
|
Hideki Nagase; Yoshinori Nakachi; Keiji Ishida; Mamoru Kiniwa; Satoshi Takeuchi; Ichiro Katayama; Yoshinari Matsumoto; Fukumi Furukawa; Shin Morizane; Sakae Kaneko; Yoshiki Tokura; Motoi Takenaka; Yutaka Hatano; Yoshiki Miyachi
|
10.2174/1874372201206010042
|
1
|
57 |
Effects of Coenzyme Q10 Administration in Amyotrophic Lateral Sclerosis (ALS). Report of a Case and Review
|
The Open Nutraceuticals Journal
|
Terukazu Kawasaki; R. B. Singh; Cornelissen Germaine; Franz Halberg
|
10.2174/1876396001205010187
|
3
|
58 |
P2X4 Receptors of Microglia in Neuropathic Pain
|
CNS & Neurological Disorders Drug Targets
|
Kazuhide Inoue; Makoto Tsuda
|
10.2174/187152712803581065
|
16
|
59 |
Pt and Pd based catalysts with novel alloy and core-shell nanostructures for practical applications in next fuel cells: Patents and highlights
|
Recent Patents On Materials Sciencee
|
Nguyen Viet Long; Cao Minh Thi; Masayuki Nogami; Michitaka Ohtaki
|
10.2174/1874464811205030175
|
4
|
60 |
Intracellular Logistics of BST-2/Tetherin
|
Current HIV Research
|
Hideaki Fujita; Keiko Fujimoto; Kenzo Tokunaga; Yoshitaka Tanaka
|
10.2174/157016212800792522
|
4
|
61 |
Auditory and Visual Mismatch Negativity in Psychiatric Disorders: A Review
|
Current Psychiatry Reviews
|
Toshihiko Maekawa; Shogo Hirano; Toshiaki Onitsuka
|
10.2174/1573400511208020097
|
20
|
62 |
Crystallization Strategy for the Glycoprotein-Receptor Complex Between Measles Virus Hemagglutinin and Its Cellular Receptor SLAM
|
Protein And Peptide Letters
|
Takao Hashiguchi; Toyoyuki Ose; Marie Kubota; Nobuo Maita; Jun Kamishikiryo; Katsumi Maenaka; Yusuke Yanagi
|
10.2174/092986612799789314
|
1
|
63 |
PDGF receptor β signaling in pericytes following ischemic brain injury.
|
Current Neurovascular Research
|
Koichi Arimura; Tetsuro Ago; Masahiro Kamouchi; Kuniyuki Nakamura; Koji Ishitsuka; Junya Kuroda; Hiroshi Sugimori; Hiroaki Ooboshi; Tomio Sasaki; Takanari Kitazono
|
10.2174/156720212799297100
|
78
|
64 |
Preparation of Cationic Comb-Type Copolymer having Tetra-Alkylammonium Groups and its Interaction with DNA
|
Current Nanoscience
|
Rui Moriyama; Junji Mochida; Asako Yamayoshi; Naohiko Shimada; Arihiro Kano; Atsushi Maruyama
|
10.2174/157341311798220600
|
2
|
65 |
Anti-Inflammatory Gene Therapy for Cardiovascular Disease
|
Current Gene Therapy
|
Tetsuya Matoba; Kensuke Egashira
|
10.2174/156652311798192888
|
21
|
66 |
Pleiotropic effects of glucagon-like peptide-1 (GLP-1)-based therapies on vascular complications in diabetes.
|
Current Pharmaceutical Design
|
Sho-ichi Yamagishi; Takanori Matsui
|
10.2174/138161211798999456
|
30
|
67 |
Androgen Receptor Cofactors in Prostate Cancer: Potential Therapeutic Targets of Castration-Resistant Prostate Cancer
|
Current Cancer Drug Targets
|
Masaki Shiota; Akira Yokomizo; Naohiro Fujimoto; Seiji Naito
|
10.2174/156800911796798904
|
36
|
68 |
A Role for SNX1 in the Regulation of EGF-Dependent Phosphorylated EGFR Endocytosis Via the Early/Late Endocytic Pathway in a Gefitinib-Sensitive Human Lung Cancer Cells
|
Current Signal Transduction Therapy
|
Yukio Nishimura; Kiyoko Yoshioka; Soichi Takiguchi; Biborka Bereczky; Yusaku Nakabeppu; Kazuyuki Itoh
|
10.2174/157436211797484047
|
6
|
69 |
Structural and functional diversity of lantibiotic immunity proteins.
|
Current Pharmaceutical Biotechnology
|
Ken Ichi Okuda; Kenji Sonomoto
|
10.2174/138920111796117274
|
8
|
70 |
Methodologies and Strategies for the Bioengineering of Lantibiotics
|
Current Pharmaceutical Biotechnology
|
Jun Ichi Nagao; Mami Nishie; Kenji Sonomoto
|
10.2174/138920111796117355
|
8
|
71 |
The principle and the potential approach to ROS-dependent cytotoxicity by non-pharmaceutical therapies: optimal use of medical gases with antioxidant properties.
|
Current Pharmaceutical Design
|
Mami Noda; Kyota Fujita; Chih Hung Lee; Tohru Yoshioka
|
10.2174/138161211797052600
|
10
|
72 |
Anti-Inflammatory Properties of Antipsychotics Via Microglia Modulations: Are Antipsychotics a ‘Fire Extinguisher’ in the Brain of Schizophrenia?
|
Mini Reviews In Medicinal Chemistry
|
Takahiro A. Kato; Akira Monji; Yoshito Mizoguchi; Sadayuki Hashioka; Hideki Horikawa; Yoshihiro Seki; Mina Kasai; Hideo Utsumi; Shigenobu Kanba
|
10.2174/138955711795906941
|
91
|
73 |
Possible role of BDNF-induced microglial intracellular Ca(2+) elevation in the pathophysiology of neuropsychiatric disorders.
|
Mini Reviews In Medicinal Chemistry
|
Yoshito Mizoguchi; Akira Monji; Takahiro A. Kato; Hideki Horikawa; Yoshihiro Seki; Mina Kasai; Shigenobu Kanba; Shigeto Yamada
|
10.2174/138955711795906932
|
16
|
74 |
Association analysis of the adenosine A1 receptor gene polymorphisms in patients with methamphetamine dependence/psychosis.
|
Current Neuropharmacology
|
Hideaki Kobayashi; Hiroshi Ujike; Nakao Iwata; Toshiya Inada; Mitsuhiko Yamada; Yoshimoto Sekine; Naohisa Uchimura; Masaomi Iyo; Norio Ozaki; Masanari Itokawa; Ichiro Sora
|
10.2174/157015911795016958
|
7
|
75 |
Association Analysis of Nuclear Receptor Rev-erb Alpha Gene (NR1D1) and Japanese Methamphetamine Dependence.
|
Current Neuropharmacology
|
Taro Kishi; Tsuyoshi Kitajima; Kunihiro Kawashima; Tomo Okochi; Yoshio Yamanouchi; Yoko Kinoshita; Hiroshi Ujike; Toshiya Inada; Mitsuhiko Yamada; Naohisa Uchimura; Ichiro Sora; Masaomi Iyo; Norio Ozaki; Nakao Iwata
|
10.2174/157015911795017065
|
4
|
76 |
Genetic Association Analysis of NOS3 and Methamphetamine-Induced Psychosis Among Japanese.
|
Current Neuropharmacology
|
Tomo Okochi; Taro Kishi; Masashi Ikeda; Tsuyoshi Kitajima; Yoko Kinoshita; Kunihiro Kawashima; Takenori Okumura; Tomoko Tsunoka; Yasuhisa Fukuo; Toshiya Inada; Mitsuhiko Yamada; Naohisa Uchimura; Masaomi Iyo; Ichiro Sora; Norio Ozaki; Hiroshi Ujike; Nakao
|
10.2174/157015911795017119
|
4
|
77 |
Association Between 5HT1b Receptor Gene and Methamphetamine Dependence
|
Current Neuropharmacology
|
Hiroshi Ujike; Makiko Kishimoto; Yuko Okahisa; Masafumi Kodama; Manabu Takaki; Toshiya Inada; Naohisa Uchimura; Mitsuhiko Yamada; Nakao Iwata; Masaomi Iyo; Ichiro Sora; Norio Ozaki
|
10.2174/157015911795017137
|
6
|
78 |
Immunochemical Approach Using Monoclonal Antibody against Δ 9-Tetrahydrocannabinolic Acid (THCA) to Discern Cannabis Plants and to Investigate New Drug Candidates
|
Current Drug Discovery Technologies
|
Hiroyuki Tanaka
|
10.2174/157016311794519974
|
1
|
79 |
No association between GRM3 and Japanese methamphetamine induced psychosis
|
Current Neuropharmacology
|
Tomoko Tsunoka; Taro Kishi; Masashi Ikeda; Tsuyoshi Kitajima; Yoshio Yamanouchi; Yoko Kinoshita; Kunihiro Kawashima; Tomo Okochi; Takenori Okumura; Toshiya Inada; Hiroshi Ujike; Mitsuhiko Yamada; Naohisa Uchimura; Ichiro Sora; Masaomi Iyo; Norio Ozaki; Na
|
10.2174/157015911795017001
|
1
|
80 |
Association Study of Serine Racemase Gene with Methamphetamine Psychosis
|
Current Neuropharmacology
|
E. Yokobayashi; Hiroshi Ujike; Tatsuya Kotaka; Yuko Okahisa; Manabu Takaki; Masafumi Kodama; Toshiya Inada; Naohisa Uchimura; Mitsuhiko Yamada; Nakao Iwata; Masaomi Iyo; Ichiro Sora; Norio Ozaki; Shigetoshi Kuroda
|
10.2174/157015911795017092
|
2
|
81 |
Advanced glycation end products (AGEs), oxidative stress and diabetic retinopathy.
|
Current Pharmaceutical Biotechnology
|
Sho-ichi Yamagishi; Takanori Matsui
|
10.2174/138920111794480534
|
62
|
82 |
Association analysis of the tryptophan hydroxylase 2 gene polymorphisms in patients with methamphetamine dependence/psychosis.
|
Current Neuropharmacology
|
Hideaki Kobayashi; Hiroshi Ujike; Nakao Iwata; Toshiya Inada; Mitsuhiko Yamada; Yoshimoto Sekine; Naohisa Uchimura; Masaomi Iyo; Norio Ozaki; Masanari Itokawa; Ichiro Sora
|
10.2174/157015911795017335
|
4
|
83 |
Association between the Regulator of G-protein Signaling 9 Gene and Patients with Methamphetamine Use Disorder and Schizophrenia.
|
Current Neuropharmacology
|
Yuko Okahisa; Masafumi Kodama; Manabu Takaki; Toshiya Inada; Naohisa Uchimura; Mitsuhiko Yamada; Nakao Iwata; Masaomi Iyo; Ichiro Sora; Norio Ozaki; Hiroshi Ujike
|
10.2174/157015911795017029
|
7
|
84 |
Lack of association between prokineticin 2 gene and Japanese methamphetamine dependence.
|
Current Neuropharmacology
|
Taro Kishi; Tsuyoshi Kitajima; Tomoko Tsunoka; Takenori Okumura; Kunihiro Kawashima; Tomo Okochi; Yoshio Yamanouchi; Yoko Kinoshita; Hiroshi Ujike; Toshiya Inada; Mitsuhiko Yamada; Naohisa Uchimura; Ichiro Sora; Masaomi Iyo; Norio Ozaki; Nakao Iwata
|
10.2174/157015911795016994
|
4
|
85 |
Helix conformation of a small peptide melittin in a methanol-water mixed solvent studied by NMR.
|
Protein And Peptide Letters
|
Yoshinori Miura
|
10.2174/092986611794578387
|
3
|
86 |
Association Study of Two Cannabinoid Receptor Genes, CNR1 and CNR2, with Methamphetamine Dependence.
|
Current Neuropharmacology
|
Yuko Okahisa; Masafumi Kodama; Manabu Takaki; Toshiya Inada; Naohisa Uchimura; Mitsuhiko Yamada; Nakao Iwata; Masaomi Iyo; Ichiro Sora; Norio Ozaki; Hiroshi Ujike
|
10.2174/157015911795017191
|
10
|
87 |
Protein kinase substrate profiling with a high-density peptide microarray
|
Combinatorial Chemistry & High Throughput Screening
|
Xiaoming Han; Tatsuhiko Sonoda; Takeshi Mori; Go Yamanouchi; Takayuki Yamaji; Syuhei Shigaki; Takuro Niidome; Yoshiki Katayama
|
10.2174/138620710792927402
|
18
|
88 |
Melanin Biosynthesis Inhibitors from Wood of Artocarpus heterophyllus: The Effect of Isoprenoid Substituent of Flavone with 4-Substituted Resorcinol Moiety at B Ring
|
Letters In Drug Design & Discovery
|
Enos Tangke Arung; Kuniyoshi Shimizu; Hiroyuki Tanaka; Ryuichiro Kondo
|
10.2174/157018010792062777
|
4
|
89 |
The pathogenesis, complications and therapeutic strategy for hepatitis C virus-associated insulin resistance in the era of anti-viral treatment.
|
Reviews On Recent Clinical Trials
|
Takumi Kawaguchi; Eitaro Taniguchi; Minoru Itou; Shuji Sumie; Sho-ichi Yamagishi; Michio Sata
|
10.2174/157488710792007257
|
10
|
90 |
Neurotoxicity of β-amyloid protein: oligomerization, channel formation, and calcium dyshomeostasis.
|
Current Pharmaceutical Design
|
Masahiro Kawahara
|
10.2174/138161210793176545
|
66
|
91 |
Spectrum of Unusual Imaging Findings of Metastatic Lesions from Gastric Cancer
|
Current Medical Imaging Reviews
|
Kousei Ishigami; Kengo Yoshimitsu; Hiroyuki Irie; Tsuyoshi Tajima; Akihiro Nishie; Masakazu Hirakawa; Yasuhiro Ushijima; Daisuke Okamoto; Akihiro Ino; Eriko Kiyosawa; Masahiro Sakai; Aya Hirata; Hiroshi Honda
|
10.2174/157340510791636309
|
0
|
92 |
Smooth muscle cell pathophysiology and advanced glycation end products (AGEs).
|
Current Drug Targets
|
Sho-ichi Yamagishi; Takanori Matsui
|
10.2174/138945010791320827
|
26
|
93 |
Pathophysiological Role of Pigment Epithelium-Derived Factor (PEDF) in Hepatic Disorders
|
Current Medicinal Chemistry
|
Sho-ichi Yamagishi; Takanori Matsui; Takumi Kawaguchi; Michio Sata
|
10.2174/092986710791233670
|
14
|
94 |
A Case of Chronic Infectious Arthritis of the Temporomandibular Joint Associated with Osteomyelitis without Malocclusion
|
The Open Dentistry Journal
|
Shinji Kito; Souichi Hirashima; Izumi Yoshioka; Manabu Habu; Masaaki Kodama; Shinya Kokuryo; Masafumi Oda; Tatsurou Tanaka; Nao Wakasugi-Sato; Shinobu Matsumoto-Takeda; Yuji Seta; Kazuhiro Tominaga; Yasuhiro Morimoto
|
10.2174/1874210601004010029
|
7
|
95 |
Anti-vasopermeability effects of PEDF in retinal-renal disorders.
|
Current Molecular Medicine
|
Seiji Ueda; Sho-ichi Yamagishi; Seiya Okuda
|
10.2174/156652410791065291
|
16
|
96 |
Structure-Function Relationships of PEDF
|
Current Molecular Medicine
|
Takumi Kawaguchi; Sho-ichi Yamagishi; M. Sata
|
10.2174/156652410791065255
|
42
|
97 |
Anti-atherothrombogenic properties of PEDF.
|
Current Molecular Medicine
|
Sho-ichi Yamagishi; Matsui T
|
10.2174/156652410791065264
|
35
|
98 |
Development of enzyme-linked immunosorbent assay system for PEDF and its clinical utility.
|
Current Molecular Medicine
|
Kei Fukami; Sho-ichi Yamagishi; Seiya Okuda
|
10.2174/156652410791065318
|
10
|
99 |
Evidence for the Binding of Phosphate Ion to the C-Terminus Region in Aβ1-40 Using Heteronuclear NMR Analyses
|
Protein And Peptide Letters
|
Makiko Nagata-Uchiyama; Yoshito Abe; Akira Monji; Shigenobu Kanba; Tadashi Ueda
|
10.2174/092986610790226058
|
0
|
100 |
Effect of protein concentration and pH on the chitinase activity of Tapes japonica lysozyme.
|
Protein And Peptide Letters
|
Takashi Goto; Yoshito Abe; Taiji Imoto; Tadashi Ueda
|
10.2174/092986610790226094
|
2
|
101 |
Irbesartan inhibits albumin-elicited proximal tubular cell apoptosis and injury in vitro.
|
Protein And Peptide Letters
|
Takanori Matsui; Sho-ichi Yamagishi; Seiji Ueda; Kei Fukami; Seiya Okuda
|
10.2174/092986610789909430
|
12
|
102 |
The Modulation of Synaptic Transmission by the Glial Purinergic System
|
The Open Neuroscience Journal
|
Kazuhide Inoue; Fusao Kato; Makoto Tsuda
|
10.2174/1874082001004010084
|
6
|
103 |
Branched-Chain Amino Acids and Pigment Epithelium-Derived Factor: Novel Therapeutic Agents for Hepatitis C Virus-Associated Insulin Resistance
|
Current Medicinal Chemistry
|
Takumi Kawaguchi; Sho-ichi Yamagishi; Michio Sata
|
10.2174/092986709789909620
|
28
|
104 |
Methyl Ganoderic Acid DM: A Selective Potent Osteoclastogenesis Inhibitor
|
The Open Bioactive Compounds Journal
|
Jie Liu; Jun Shiono; Yukiko Tsuji; Kuniyoshi Shimizu; Ryuichiro Kondo
|
10.2174/1874847300902010037
|
5
|
105 |
New Trends and Advances in Oral and Maxillofacial Imaging
|
Current Medical Imaging Reviews
|
Yasuhiro Morimoto; Tatsurou Tanaka; Noriaki Yamamoto; Masaaki Kodama; Yuji Seta; Manabu Habu; Masafumi Oda; Shinji Kito; Nao Wakasugi-Sato; Shinobu Matsumoto-Takeda; Yasuhiro Fukai; Takatoshi Tokitsu; Megumi Tomikawa; Kazunari Matoba; Yoshihiro Yamashita;
|
10.2174/157340509790112790
|
8
|
106 |
HLA-G Molecule
|
Current Pharmaceutical Design
|
Jun Kamishikiryo; Katsumi Maenaka
|
10.2174/138161209789105153
|
15
|
107 |
Recent understanding of leukocytapheresis (LCAP) for the treatment of inflammatory bowel disease.
|
Current Pharmaceutical Design
|
Keiichi Mitsuyama; Hiroshi Yamasaki; Kotaro Kuwaki; Hidetoshi Takedatsu; Michio Sata
|
10.2174/138161209788489104
|
14
|
108 |
Crystallization and preliminary X-ray analysis of the low-affinity complex between human leukocyte antigen-G (HLA-G) and leukocyte Ig-like receptor B2 (LILRB2).
|
Protein And Peptide Letters
|
Mitsunori Shiroishi; Katsumi Maenaka
|
10.2174/092986609787848108
|
2
|
109 |
Evaluation of Novel Radioiodinated C7-substituted Δ6,7 – estradiol Derivatives for Molecular Recognition of ER-Positive Breast Tumours
|
Current Radiopharmaceuticalse
|
Carina Neto; Maria Cristina Oliveira; Lurdes Gano; Fernanda Marques; Isabel Santos; Goreti Ribeiro Morais; Takumi Yasuda; Thies Thiemann; Filomena Botelho; Carlos F. Oliveira
|
10.2174/1874471010902020083
|
6
|
110 |
Screening of dipeptides having central functions for excitation and sedation.
|
Mini Reviews In Medicinal Chemistry
|
Haruka Yamane; D. M. Denbow; Mitsuhiro Furuse
|
10.2174/1389557510909030300
|
2
|
111 |
Anti-inflammatory effects of antidepressants: possibilities for preventives against Alzheimer's disease.
|
Central Nervous System Agents In Medicinal Chemistry
|
Sadayuki Hashioka; Patrick L. McGeer; Akira Monji; Shigenobu Kanba
|
10.2174/187152409787601897
|
55
|
112 |
Atheroprotective properties of pigment epithelium-derived factor (PEDF) in cardiometabolic disorders.
|
Current Pharmaceutical Design
|
Sho-ichi Yamagishi; Takanori Matsui; Kazuo Nakamura
|
10.2174/138161209787581940
|
41
|
113 |
Clinical Utility of Acarbose, an α-Glucosidase Inhibitor in Cardiometabolic Disorders
|
Current Drug Metabolism
|
Sho-ichi Yamagishi; Takanori Matsui; Seiji Ueda; Kei Fukami; Seiya Okuda
|
10.2174/138920009787522133
|
39
|
114 |
Intracellular Amyloid β-Protein As a Therapeutic Target for Treating Alzheimers Disease
|
Current Alzheimer Research
|
Yasumasa Ohyagi
|
10.2174/156720508786898514
|
34
|
115 |
Genetic Polymorphisms in the Growth Hormone Receptor: Impact on Growth Response and Disease Susceptibility
|
Current Pharmacogenomics And Personalized Medicine
|
K. Ihara; T. Hara
|
10.2174/187569208786733875
|
1
|
116 |
Pigment epithelium-derived factor (PEDF): its potential therapeutic implication in diabetic vascular complications.
|
Current Drug Targets
|
Sho-ichi Yamagishi; Takanori Matsui; Kazuo Nakamura; So Ueda; Yoshihiro Noda; Tsutomu Imaizumi
|
10.2174/138945008786786154
|
35
|
117 |
Radar chart deviation analysis of prion protein amino acid composition defines characteristic structural abnormalities of the N-terminal octapeptide tandem repeat
|
Protein And Peptide Letters
|
Satoru Yokotani; Takeru Nose; Yuji Horiuchi; Ayami Matsushima; Yasuyuki Shimohigashi
|
10.2174/092986608785849182
|
2
|
118 |
Role of Asymmetric Dimethylarginine (ADMA) in Diabetic Vascular Complications
|
Current Pharmaceutical Design
|
Sho-ichi Yamagishi; Seiji Ueda; Kazuo Nakamura; Takanori Matsui; Seiya Okuda
|
10.2174/138161208786071326
|
36
|
119 |
Current status and perspectives regarding the treatment of osteo-sarcoma: chemotherapy.
|
Reviews On Recent Clinical Trials
|
Akio Sakamoto; Yukihide Iwamoto
|
10.2174/157488708785700267
|
86
|
120 |
Telmisartan inhibits advanced glycation end products (AGEs)-elicited endothelial cell injury by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-γ activation
|
Protein And Peptide Letters
|
Sho-ichi Yamagishi; Takanori Matsui; Kazuo Nakamura; Masayoshi Takeuchi; Hiroyoshi Inoue
|
10.2174/092986608785203746
|
41
|
121 |
Drug Delivery System Based on Responses to an HIV Infectious Signal
|
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
Daisuke Asai; Kota Kodama; Yoko Shoji; Hideaki Nakashima; Kenji Kawamura; Jun Oishi; Masanori Kuramoto; Takuro Niidome; Yoshiki Katayama
|
10.2174/157340608784872307
|
5
|
122 |
Role of AGEs in Diabetic Nephropathy
|
Current Pharmaceutical Design
|
Kei Fukami; Sho-ichi Yamagishi; Seiji Ueda; Seiya Okuda
|
10.2174/138161208784139710
|
116
|
123 |
Clinical application of computer-aided diagnostic system for harmonious introduction of complementary dialysis therapy.
|
The Open Biomedical Engineering Journal
|
Abdullah Al Mamun; Hiroyuki Hamada; Tomokazu Karino; Shinji Namoto; Akihiro C. Yamashita; Makoto Ishizaki; Masahiro Okamoto
|
10.2174/1874120700802010010
|
1
|
124 |
Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy.
|
Current Pharmaceutical Design
|
Sho-ichi Yamagishi; Seiji Ueda; Takanori Matsui; Kazuo Nakamura; Seiya Okuda
|
10.2174/138161208784139729
|
88
|
125 |
A docking modelling rationally predicts strong binding of bisphenol A to estrogen-related receptor γ
|
Protein And Peptide Letters
|
Takeru Nose; Yasuyuki Shimohigashi
|
10.2174/092986608783744261
|
11
|
126 |
Preclinical and Clinical Studies of Novel Breast Cancer Drugs Targeting Molecules Involved in Protein Kinase C Signaling, the Putative Metastasis-Suppressor Gene Cap43 and the Y-box Binding Protein-1
|
Current Medicinal Chemistry
|
Kazuo Shirouzu; Michihiko Kuwano; Mayumi Ono; Masayoshi Kage; Uhi Toh; Teruhiko Fujii; Goro Yokoyama; Hiroki Takahashi
|
10.2174/092986708783769759
|
19
|
127 |
Deregulation of the Akt pathway in human cancer.
|
Current Cancer Drug Targets
|
Eriko Tokunaga; Eiji Oki; Akinori Egashira; Noriaki Sadanaga; Masaru Morita; Yoshihiro Kakeji; Yoshihiko Maehara
|
10.2174/156800908783497140
|
176
|
128 |
Receptor for advanced glycation end products (RAGE): a novel therapeutic target for diabetic vascular complication.
|
Current Pharmaceutical Design
|
Sho-ichi Yamagishi; Kazuo Nakamura; Takanori Matsui; Yoshihiro Noda; Tsutomu Imaizumi
|
10.2174/138161208783597416
|
84
|
129 |
Role of oxidative stress in the development of vascular injury and its therapeutic intervention by nifedipine.
|
Current Medicinal Chemistry
|
Sho-ichi Yamagishi; Kazuo Nakamura; Takanori Matsui
|
10.2174/092986708783330557
|
43
|
130 |
AFM Study on Surface Microtopography, Morphology and Crystal Growth of Hydrothermal Illite in Izumiyama Pottery Stone from Arita, Saga Prefecture, Japan
|
The Open Mineralogy Journal
|
Yoshihiro Kuwahara; Seiichiro Uehara
|
10.2174/18744567000802010034
|
3
|
131 |
Epigenetic regulation of genes encoding drug-metabolizing enzymes and transporters; DNA methylation and other mechanisms.
|
Current Drug Metabolism
|
Takeshi Hirota; Hiroshi Takane; Shun Higuchi; Ichiro Ieiri
|
10.2174/138920008783331130
|
25
|
132 |
Recent progress and challenges in nanotechnology for biomedical applications: an insight into the analysis of neurotransmitters.
|
Recent Patents On Nanotechnology
|
Dhesingh Ravi Shankaran; Norio Miura
|
10.2174/187221007782360484
|
6
|
133 |
Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes.
|
Current Drug Targets
|
Sho-ichi Yamagishi; Takanori Matsui; Kazuo Nakamura
|
10.2174/138945007782151298
|
62
|
134 |
Two Different Functions of Doxycycline Which is Both An Antimicrobial Agent and An Immune Modulator
|
Anti-Infective Agents In Medicinal Chemistry
|
Masaki Fujita; Yoichi Nakanishi
|
10.2174/187152107782023097
|
2
|
135 |
Food-Derived Advanced Glycation end Products (AGEs): A Novel Therapeutic Target for Various Disorders
|
Current Pharmaceutical Design
|
Sho-ichi Yamagishi; Seiji Ueda; Seiya Okuda
|
10.2174/138161207781757051
|
96
|
136 |
Pigment epithelium-derived factor (PEDF) prevents advanced glycation end products (AGEs)-elicited endothelial nitric oxide synthase (eNOS) reduction through its anti-oxidative properties.
|
Protein And Peptide Letters
|
Sho-ichi Yamagishi; Seiji Ueda; Takanori Matsui; Kazuo Nakamura; Tsutomu Imaizumi; Masayoshi Takeuchi; Seiya Okuda
|
10.2174/092986607781483705
|
36
|
137 |
Potential Utility of Telmisartan, an Angiotensin II Type 1 Receptor Blocker with Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ)-Modulating Activity for the Treatment of Cardiometabolic Disorders
|
Current Molecular Medicine
|
Sho-ichi Yamagishi; Kazuo Nakamura; Takanori Matsui
|
10.2174/156652407781387073
|
57
|
138 |
Recent advances in Cannabis sativa research: biosynthetic studies and its potential in biotechnology.
|
Current Pharmaceutical Biotechnology
|
Supaart Sirikantaramas; Futoshi Taura; Satoshi Morimoto; Yukihiro Shoyama
|
10.2174/138920107781387456
|
64
|
139 |
Molecular mechanisms of diabetic nephropathy and its therapeutic intervention.
|
Current Drug Targets
|
Sho-ichi Yamagishi; Kei Fukami; Seiji Ueda; Seiya Okuda
|
10.2174/138945007781386884
|
129
|
140 |
Expression and Purification of Uniformly 15N-Labeled Amyloid β Peptide 1-40 in Escherichia coli
|
Protein And Peptide Letters
|
M. Nagata-Uchiyama; M. Yaguchi; Y. Hirano; Tadashi Ueda
|
10.2174/092986607781483741
|
14
|
141 |
Advanced glycation end products (AGEs) and cardiovascular disease (CVD) in diabetes.
|
Cardiovascular & Hematological Agents In Medicinal Chemistry
|
Sho-ichi Yamagishi; Takanori Matsui; Shinichiro Ueda; Kazuo Nakamura; Tsutomu Imaizumi
|
10.2174/187152507781058681
|
29
|
142 |
Protective substances against zinc-induced neuronal death after ischemia: carnosine as a target for drug of vascular type of dementia.
|
Recent Patents On CNS Drug Discovery
|
Masahiro Kawahara; Keiko Konoha; Tetsuya Nagata; Yutaka Sadakane
|
10.2174/157488907780832698
|
27
|
143 |
Novel therapeutic targets for diabetic nephropathy.
|
Endocrine, Metabolic & Immune Disorders Drug Targets
|
Kei Fukami; Sho-ichi Yamagishi; Seiji Ueda; Seiya Okuda
|
10.2174/187153007780832118
|
23
|
144 |
Pigment Epithelium-Derived Factor (PEDF) Inhibits Angiotensin IIInduced Smooth Muscle Cell Proliferation Through Its Anti-Oxidative Properties
|
Protein And Peptide Letters
|
Sho-ichi Yamagishi; Takanori Matsui; Kazuo Nakamura; Tsutomu Imaizumi
|
10.2174/092986607780989976
|
7
|
145 |
Physiological and pathophysiological roles of ATP-sensitive K+ channels in vascular smooth muscle
|
Vascular Disease Prevention
|
Noriyoshi Teramoto; William C. Cole
|
10.2174/156727007780599476
|
1
|
146 |
Galloyl Group is not Necessary for a Sedative Effect of Catechin Through GABAergic System
|
Letters In Drug Design & Discovery
|
Nami Adachi; Shozo Tomonaga; Rie Suenaga; D. Michael Denbow; Mitsuhiro Furuse
|
10.2174/157018007780077444
|
4
|
147 |
Molecular mechanisms of the antiatherogenic action of adiponectin
|
Vascular Disease Prevention
|
Kunihisa Kobayashi; Toyoshi Inoguchi
|
10.2174/156727007779802714
|
1
|
148 |
Role of Endogenous Inhibitors of Cytokine Signaling in Allergic Asthma
|
Current Medicinal Chemistry
|
Hiromasa Inoue; Satoru Fukuyama; Koichiro Matsumoto; Masato Kubo; Akihiko Yoshimura
|
10.2174/092986707779313327
|
24
|
149 |
Membrane Interactive α-Helices in GPCRs as a Novel Drug Target
|
Current Protein & Peptide Science
|
Wataru Nemoto; Hiroyuki Toh
|
10.2174/138920306779025657
|
21
|
150 |
Molecular Basis for Invertebrate Innate Immune Recognition of (1→3)-β- D-Glucan as A Pathogen-Associated Molecular Pattern
|
Current Pharmaceutical Design
|
Tatsushi Muta
|
10.2174/138161206778743529
|
21
|
151 |
Intracellular Amyloid β-Protein and Its Associated Molecules in the Pathogenesis of Alzheimers Disease
|
Mini Reviews In Medicinal Chemistry
|
Yasumasa Ohyagi; Takeshi Tabira
|
10.2174/138955706778560175
|
24
|
152 |
A Simple Search of TM Segments in Polytopic Membrane Protein Using Matrix - Assisted Laser DesorptionIonization Time - of - Flight Mass Spectrometry
|
Protein And Peptide Letters
|
Yoshito Abe; Tomohiro Hamasaki; Susumu Turusaki; Shinya Takazaki; Xiuri Jin; Dongchon Kang; Naotaka Hamasaki
|
10.2174/092986606777841316
|
3
|
153 |
C7-Substituted Estranes and Related Steroids
|
Mini-Reviews In Organic Chemistry
|
Goreti Ribeiro Morais; Naho Yoshioka; Masataka Watanabe; Shuntaro Mataka; Cristina das Neves Oliveira; Thies Thiemann
|
10.2174/1570193x10603030229
|
2
|
154 |
Induction of the hepatic cytochrome P450 2B subfamily by xenobiotics: research history, evolutionary aspect, relation to tumorigenesis, and mechanism.
|
Current Drug Metabolism
|
Hideyuki Yamada; Yuji Ishii; Midori Yamamoto; Kazuta Oguri
|
10.2174/138920006776873508
|
35
|
155 |
Pigment Epithelium-Derived Factor (PEDF) Blocks Angiotensin IIInduced T Cell Proliferation by Suppressing Autocrine Production of Interleukin-2
|
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
Hiroyoshi Inoue; Masayoshi Takeuchi; Takanori Matsui; Sho-ichi Yamagishi; Seiji Kikuchi; Kazuo Nakamura
|
10.2174/157340606776930826
|
12
|
156 |
Atorvastatin and diabetic vascular complications.
|
Current Pharmaceutical Design
|
Sho-ichi Yamagishi; Takanori Matsui; Kazuo Nakamura
|
10.2174/138161206776389796
|
18
|
157 |
Pleiotropic Effects of Nifedipine on Atherosclerosis
|
Current Pharmaceutical Design
|
Sho-ichi Yamagishi; Kazuo Nakamura; Katsuhiko Takenaka; Takanori Matsui; Hiroyoshi Inoue
|
10.2174/138161206776389877
|
22
|
158 |
Cardiovascular disease in diabetes.
|
Mini Reviews In Medicinal Chemistry
|
Sho-ichi Yamagishi; Kazuo Nakamura; Takanori Matsui; Katsuhiko Takenaka; Yuko Jinnouchi; Tsutomu Imaizumi
|
10.2174/138955706776073501
|
23
|
159 |
Advanced Glycation End Products (AGEs) and their Receptor (RAGE) System in Diabetic Retinopathy
|
Current Drug Discovery Technologies
|
Sho-ichi Yamagishi; Kazuo Nakamura; Takanori Matsui
|
10.2174/157016306776637555
|
36
|
160 |
Anti-hyperglycemic Potential of Natural Products.
|
Mini Reviews In Medicinal Chemistry
|
Takanori Matsui; I. A. Ogunwande; K. J M Abesundara; K. Matsumoto
|
10.2174/138955706776073484
|
102
|
161 |
Role of advanced glycation end products (AGEs) in thrombogenic abnormalities in diabetes.
|
Current Neurovascular Research
|
Katsuhiko Takenaka; Sho-ichi Yamagishi; Takanori Matsui; Kazuo Nakamura; Tsutomu Imaizumi
|
10.2174/156720206775541804
|
64
|
162 |
Development of a fluorescence peptide chip for the detection of caspase activity.
|
Combinatorial Chemistry & High Throughput Screening
|
Aishan Han; Tatsuhiko Sonoda; Jeong Hun Kang; Masaharu Murata; Takuro Niiidome; Yoshiki Katayama
|
10.2174/138620706775213831
|
8
|
163 |
Telmisartan, its potential therapeutic implications in cardiometabolic disorders.
|
Recent Patents On Cardiovascular Drug Discovery
|
Sho-ichi Yamagishi; Kazuo Nakamura
|
10.2174/157489006775244281
|
2
|
164 |
Circular dichroism in a chiral amide possessing an achiral binaphthyl chromophore
|
Letters In Organic Chemistry
|
Shinzo Hosoi; Jun Serata; Akiyo Sakushima; Fumiyuki Kiuchi; Ichiro Takahashi; Tomihisa Ohta
|
10.2174/157017806774964404
|
3
|
165 |
Laminin and its Related Peptides for the Treatment of Alzheimers Disease
|
Current Medicinal Chemistry-Central Nervous System Agents
|
Akira Monji; Ken Ichiro Tashiro; Ichiro Yoshida; Sadayuki Hashioka; Takahiro A. Kato; Shigenobu Kanba
|
10.2174/156801505774913017
|
1
|
166 |
Statin Attenuates High Glucose-Induced and Angiotensin II-Induced MAP Kinase Activity Through Inhibition of NAD(P)H Oxidase Activity in Cultured Mesangial Cells
|
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
Hai Yan Yu; Toyoshi Inoguchi; Mieko Nakayama; Hirotaka Tsubouchi; Naoichi Sato; Noriyuki Sonoda; Shuji Sasaki; Kunihisa Kobayashi; Hajime Nawata
|
10.2174/1573406054864052
|
22
|
167 |
Diabetic Vascular Complications: Pathophysiology, Biochemical Basis and Potential Therapeutic Strategy
|
Current Pharmaceutical Design
|
Sho-ichi Yamagishi; Tsutomu Imaizumi
|
10.2174/1381612054367300
|
379
|
168 |
NAD(P)H Oxidase Activation: A Potential Target Mechanism for Diabetic Vascular Complications, Progressive β-Cell Dysfunction and Metabolic Syndrome
|
Current Drug Targets
|
Toyoshi Inoguchi; Hajime Nawata
|
10.2174/1389450054021927
|
102
|
169 |
Regulation of the Neuronal Fate by ΔFosB and its Downstream Target, Galectin-1
|
Current Drug Targets
|
Tomofumi Miura; Yoshinori N. Ohnishi; H. Kurushima; Hidenori Horie; Toshihiko Kadoya; Yusaku Nakabeppu
|
10.2174/1389450054021963
|
18
|
170 |
TRP Channels as A Newly Emerging Non-Voltage-Gated Ca2+ Entry Channel Superfamily
|
Current Pharmaceutical Design
|
Ryuji Inoue
|
10.2174/1381612054021079
|
27
|
171 |
Adipokines: therapeutic targets for metabolic syndrome.
|
Current Drug Targets
|
Kunihisa Kobayashi
|
10.2174/1389450054021972
|
60
|
172 |
Design of a new phosphate binder, anion exchange resin, based on microcalorimeter measurements
|
Letters In Drug Design & Discovery
|
Hiroyoshi Inoue; Sho-ichi Yamagishi
|
10.2174/1570180053765138
|
0
|
173 |
Alterations of mitochondrial DNA in common diseases and disease states: aging, neurodegeneration, heart failure, diabetes, and cancer.
|
Current Medicinal Chemistry
|
Dongchon Kang; Naotaka Hamasaki
|
10.2174/0929867053363081
|
115
|
174 |
Advanced glycation end products (AGEs) and diabetic vascular complications.
|
Current Diabetes Reviews
|
Sho-ichi Yamagishi; Kazuo Nakamura; Tsutomu Imaizumi
|
10.2174/1573399052952631
|
126
|
175 |
Apoptosis signaling pathways in lung diseases.
|
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
Kazuyoshi Kuwano; Michihiro Yoshimi; Takashige Maeyama; Naoki Hamada; Mizuho Yamada; Yoichi Nakanishi
|
10.2174/1573406053402497
|
27
|
176 |
Disruption of Calcium Homeostasis in the Pathogenesis of Alzheimers Disease and Other Conformational Diseases
|
Current Alzheimer Research
|
Masahiro Kawahara
|
10.2174/1567205043332234
|
44
|
177 |
Prostaglandin J2 Family and the Cardiovascular System
|
Current Vascular Pharmacology
|
Toshiyuki Sasaguri; Yoshikazu Miwa
|
10.2174/1570161043476384
|
19
|
178 |
Comparative receptor surface analysis of agonists for tyramine receptor which inhibit sex-pheromone production in Plodia interpunctella.
|
Combinatorial Chemistry & High Throughput Screening
|
Akinori Hirashima; Tomohiko Eiraku; Eiichi Kuwano; Morifusa Eto
|
10.2174/138620704773120775
|
6
|
179 |
Endothelial Dysfunction and Coronary Atherosclerosis
|
Current Drug Targets. Cardiovascular & Haematological Disorders
|
Shiro Kitamoto; Kensuke Egashira
|
10.2174/1568006043481257
|
14
|
180 |
Suppression of Virulence of Porphyromonas gingivalis by Potent Inhibitors Specific for Gingipains
|
Current Protein & Peptide Science
|
Tomoko Kadowaki; Kenji Yamamoto
|
10.2174/1389203033486992
|
25
|
181 |
Mitochondria-targeting therapeutic strategies for overcoming chemoresistance and progression of cancer.
|
Current Medicinal Chemistry
|
Takashi Morisaki; Mitsuo Katano
|
10.2174/0929867033456431
|
32
|
182 |
A Possible Target of Antioxidative Therapy for Diabetic Vascular Complications-Vascular NAD(P)H Oxidase
|
Current Medicinal Chemistry
|
Toyoshi Inoguchi; Hirotaka Tsubouchi; T. Etoh; Maiko Kakimoto; Toshiyo Sonta; Hideo Utsumi; Hideki Sumimoto; Hai Yan Yu; Noriyuki Sonoda; Mieko Inuo; Naoichi Sato; Naotaka Sekiguchi; Kunihisa Kobayashi; Hajime Nawata
|
10.2174/0929867033457133
|
39
|
183 |
New target molecules in the drug control of blood pressure and circulation.
|
Current Drug Targets. Cardiovascular & Haematological Disorders
|
Ryuji Inoue; Yasuo Mori
|
10.2174/1568006033337348
|
3
|
184 |
Kinetic and Site-Directed Mutagenesis Studies of Prevotella Intermedia Acid Phosphatase
|
Protein And Peptide Letters
|
Xiaochi Chen; Toshihiro Ansai; Sailen Barik; Tadamichi Takehara
|
10.2174/0929866033408282
|
3
|
185 |
Effects of stereochemistry of sugars on protein stabilities.
|
Protein And Peptide Letters
|
Kiyonari Masumoto; Tadashi Ueda; Makiko Nagata; Yuko Yamada; Yuichiro Yoshida; Yoshio Hashimoto; Taiji Imoto
|
10.2174/0929866023408553
|
4
|
186 |
Molecular mechanisms of pulmonary fibrosis and current treatment.
|
Current Molecular Medicine
|
Kazuyoshi Kuwano; Naoki Hagimoto; Nobuyuki Hara
|
10.2174/1566524013363401
|
56
|
187 |
Antibody-Scanning and Epitope-Tagging Methods Molecular Mapping of Proteins Using Antibodies
|
Current Protein & Peptide Science
|
Tetsuya Toyoda; Kenji Masunaga; Y. Ohtus; Koyu Hara; Nobuyuki Hamada; Takahito Kashiwagi; Jun Iwahashi
|
10.2174/1389203003381360
|
10
|
188 |
Enhancement of contractile force generation of artificial skeletal muscle tissues by mild and transient heat treatment.
|
Current Pharmaceutical Biotechnology
|
Masanori Sato; Kazushi Ikeda; Shota Kanno; Akira Ito; Yoshinori Kawabe; Masamichi Kamihira
|
10.2174/1389201015666140408125231
|
3
|